168 related articles for article (PubMed ID: 29699498)
1. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.
Bakos Z; Chatterjee NC; Reitan C; Singh JP; Borgquist R
BMC Cardiovasc Disord; 2018 Apr; 18(1):70. PubMed ID: 29699498
[TBL] [Abstract][Full Text] [Related]
2. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
[TBL] [Abstract][Full Text] [Related]
3. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
[TBL] [Abstract][Full Text] [Related]
4. Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: retrospective study with 1 year follow up.
Polasek R; Kucera P; Nedbal P; Roubicek T; Belza T; Hanuliakova J; Horak D; Wichterle D; Kautzner J
BMC Cardiovasc Disord; 2012 May; 12():34. PubMed ID: 22607487
[TBL] [Abstract][Full Text] [Related]
5. Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study.
Truong QA; Szymonifka J; Januzzi JL; Contractor JH; Deaño RC; Chatterjee NA; Singh JP
Heart Rhythm; 2019 Jun; 16(6):928-935. PubMed ID: 30590191
[TBL] [Abstract][Full Text] [Related]
6. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population.
Sokal A; Lenarczyk R; Kowalski O; Mitrega K; Pluta S; Stabryla-Deska J; Streb W; Urbanik Z; Krzeminski TF; Kalarus Z
Heart Rhythm; 2016 May; 13(5):1088-1095. PubMed ID: 26776557
[TBL] [Abstract][Full Text] [Related]
8. Coronary sinus biomarker sampling compared to peripheral venous blood for predicting outcomes in patients with severe heart failure undergoing cardiac resynchronization therapy: the BIOCRT study.
Truong QA; Januzzi JL; Szymonifka J; Thai WE; Wai B; Lavender Z; Sharma U; Sandoval RM; Grunau ZS; Basnet S; Babatunde A; Ajijola OA; Min JK; Singh JP
Heart Rhythm; 2014 Dec; 11(12):2167-75. PubMed ID: 25014756
[TBL] [Abstract][Full Text] [Related]
9. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
10. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
Tawfik Ghanem M; Allam LE; Samir Ahmed R
Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
[TBL] [Abstract][Full Text] [Related]
11. Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure.
Yu CM; Fung JW; Zhang Q; Chan CK; Chan I; Chan YS; Kong SL; Sanderson JE; Lam CW
J Card Fail; 2005 Jun; 11(5 Suppl):S42-6. PubMed ID: 15948100
[TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia predicts adverse clinical outcomes after cardiac resynchronization therapy.
Perge P; Boros AM; Zima E; Gellér L; Merkely B; Széplaki G
Scand Cardiovasc J; 2018 Oct; 52(5):250-255. PubMed ID: 30714413
[TBL] [Abstract][Full Text] [Related]
13. Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study.
Gaggin HK; Truong QA; Rehman SU; Mohammed AA; Bhardwaj A; Parks KA; Sullivan DA; Chen-Tournoux A; Moore SA; Richards AM; Troughton RW; Lainchbury JG; Weiner RB; Baggish AL; Semigran MJ; Januzzi JL
Congest Heart Fail; 2013; 19(3):135-42. PubMed ID: 23279139
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning Prediction of Response to Cardiac Resynchronization Therapy: Improvement Versus Current Guidelines.
Feeny AK; Rickard J; Patel D; Toro S; Trulock KM; Park CJ; LaBarbera MA; Varma N; Niebauer MJ; Sinha S; Gorodeski EZ; Grimm RA; Ji X; Barnard J; Madabhushi A; Spragg DD; Chung MK
Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007316. PubMed ID: 31216884
[TBL] [Abstract][Full Text] [Related]
15. Interventricular lead separation is critical for NT-proBNP reduction after cardiac resynchronization therapy.
Lang NN; Badar AA; Pettit SJ; Templeton S; Connelly DT; Gardner RS
Biomark Med; 2014; 8(6):797-806. PubMed ID: 25224936
[TBL] [Abstract][Full Text] [Related]
16. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
Roubicek T; Stros J; Kucera P; Nedbal P; Cerny J; Polasek R; Wichterle D
PLoS One; 2019; 14(7):e0219966. PubMed ID: 31314790
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
[TBL] [Abstract][Full Text] [Related]
18. Quantification of ventricular resynchronization reserve by radionuclide phase analysis in heart failure patients: a prospective long-term study.
Dauphin R; Nonin E; Bontemps L; Vincent M; Pinel A; Bonijoly S; Barborier D; Ribier A; Fernandes CM; Bert-Marcaz P; Itti R; Chevalier P
Circ Cardiovasc Imaging; 2011 Mar; 4(2):114-21. PubMed ID: 21239562
[TBL] [Abstract][Full Text] [Related]
19. Utility of cardiac magnetic resonance imaging, echocardiography and electrocardiography for the prediction of clinical response and long-term survival following cardiac resynchronisation therapy.
Ellims AH; Pfluger H; Elsik M; Butler MJ; Hare JL; Taylor AJ
Int J Cardiovasc Imaging; 2013 Aug; 29(6):1303-11. PubMed ID: 23568562
[TBL] [Abstract][Full Text] [Related]
20. Clinical and classic echocardiographic features of patients with, and without, left ventricle reverse remodeling following the introduction of cardiac resynchronization therapy.
Wiliński J; Czarnecka D; Wojciechowska W; Kloch-Badełek M; Jastrzębski M; Bacior B; Sondej T; Kusak P; Przybyła A; Kawecka-Jaszcz K
Cardiol J; 2011; 18(2):157-64. PubMed ID: 21432822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
